ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

When you’re living with diabetes, you have to be careful. Here are 10 low-sugar marinades that still bring the flavor.

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.

A study looked at the best ways researchers can approach clinical trials on social media to encourage more people to sign up.

Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...

Carl had to be one of the most patient people ever, on TV or otherwise. Not only would the neighbor kid go up to his house anytime he pleased, but Steve Urkel was responsible for an increase of many ...

Even though we may be busy in the mornings, and many of us grab something on the go, what you eat at the beginning of the day has a tremendous effect on your body. It's not just about breakfast, it's ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

According to new data, a staggering 74% of colorectal cancer patients struggle to find someone who understands what they’re ...